Amy Schumer's Parenting Milestone With 4-Year-Old Son Gene Will Have You Exhausted

Amy Schumer is finally getting some sleep.

The comedian recently shared that she and husband Chris Fisher sought professional help after their 4-year-old son Gene stopped sleeping through the night.

"We're finally SLEEPING again," the 42-year-old posted on Instagram March 7, alongside a black and white selfie of her and Chris. "Jessica @awesomelittlesleepers helped us create a bedtime routine for our 4 year old and now he's going to bed 3 hours earlier than he was. We got our nights back! She seriously saved us."

And Amy stressed that she wasn't posting an ad for the company, but that she was "just trying to pass on the info that helped us."

Since welcoming Gene in 2019, Amy—who wed Chris in 2018—has been open about the highs and lows of motherhood.

"Being his mom is heaven on earth," the Trainwreck star wrote on Instagram in 2022, "and also means a constant feeling of guilt and vulnerability I will never get used to."

She continued, "Your heart feels like it's outside your body and you're too old to drink the feelings away like you used to. When you were in love and scared. Send help!!!"

And as she's navigated life as a working mom, she's also faced health challenges. In fact, Amy also recently shared that she's been diagnosed with Cushing Syndrome, a hormonal disorder she developed as a result of taking steroid medication, that she said resulted in a "puffier" face on her February Tonight Show and View appearances.

"While I was doing press on camera for my Hulu show, I was also in MRI machines four hours at a time, having my veins shut down from the amount of blood drawn and thinking I may not be around to see my son grow up," the Life of Beth star shared in Jessica Yellin's Feb. 23 newsletter. "So finding out I have the kind of Cushing that will just work itself out and I'm healthy was the greatest news imaginable."

For the latest breaking news updates, click here to download the E! News App

Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.